Deutsch English Français

Contact

EP1208101

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1208101

EP1208101 - VITRONECTIN RECEPTOR ANTAGONISTS USEFUL FOR THE TREATMENT OF STROKES [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 05.09.2003 Database last updated on 31.08.2024
Most recent event Tooltip	05.09.2003	Application deemed to be withdrawn	published on 22.10.2003 [2003/43]
Applicant(s)	For all designated states SMITHKLINE BEECHAM CORPORATION One Franklin Plaza Philadelphia, PA 19103 / US
	[N/P]
Former [2002/22]	For all designated states SmithKline Beecham Corporation One Franklin Plaza Philadelphia, PA 19103 / US
Inventor(s)	01 / BARONE, Frank, C. 2861 Eagleville Road Audubon, PA 19403 / US
	02 / YUE, Tian-Li 308 Earlington Road Havertown, PA 19083 / US
	[2002/22]
Representative(s)	Valentine, Jill Barbara, et al GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB
	[N/P]
Former [2002/22]	Valentine, Jill Barbara, et al GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB
Application number, filing date	00952558.5	04.08.2000
	[2002/22]
	WO2000US21433
Priority number, date	US19990147567P	06.08.1999 Original published format: US 147567 P
	[2002/22]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO0110867
	Date:	15.02.2001
	Language:	EN
	[2001/07]
	Type:	A1 Application with search report
	No.:	EP1208101
	Date:	29.05.2002
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 15.02.2001 takes the place of the publication of the European patent application.
	[2002/22]
Search report(s)	International search report - published on:	US	15.02.2001
	(Supplementary) European search report - dispatched on:	EP	30.01.2003
Classification	IPC:	C07D487/00, C07D401/12, C07D413/12, C07D417/12, A61K31/44, A61K31/47, A61P9/00	[2003/12]
	CPC:	A61K31/55 (EP); A61P17/02 (EP); A61P25/00 (EP); A61P43/00 (EP); A61P9/00 (EP)
	Former IPC [2002/22]	C07D487/00, C07D401/12, C07D413/12, C07D417/12, A61K31/44, A61K31/47
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2002/22]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	ZUR BEHANDLUNG VON SCHLAGANFÄLLEN NÜTZLICHE VITRONEKTIN-REZEPTOR-ANTAGONISTEN	[2002/22]
	English:	VITRONECTIN RECEPTOR ANTAGONISTS USEFUL FOR THE TREATMENT OF STROKES	[2002/22]
	French:	ANTAGONISTES DU RECEPTEUR DE LA VITRONECTINE UTILES POUR LE TRAITEMENT DES ACCIDENTS VASCULAIRES CEREBRAUX	[2002/22]
Entry into regional phase	15.02.2002	National basic fee paid
	15.02.2002	Search fee paid
	15.02.2002	Designation fee(s) paid
	15.02.2002	Examination fee paid
Examination procedure	20.02.2001	Request for preliminary examination filed International Preliminary Examining Authority: US
	15.02.2002	Amendment by applicant (claims and/or description)
	15.02.2002	Examination requested [2002/22]
	16.04.2003	Application deemed to be withdrawn, date of legal effect [2003/43]
	21.05.2003	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2003/43]
Fees paid	Renewal fee
	07.08.2002	Renewal fee patent year 03
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[XD]WO9814192 (SMITHKLINE BEECHAM CORP [US], et al) [XD] 1-5 * see claims, see p.2, lines 13-16 ; column W ;
		[Y]WO9906049 (SMITHKLINE BEECHAM CORP [US], et al) [Y] 1-5 * see p. 2, line 23, see claims ; column W ;
		[YD]WO9724119 (SMITHKLINE BEECHAM CORP [US], et al) [YD] 1-5 * see p. 3, lines 4-6, see claims ; column W ;
		[Y]WO9606087 (SMITHKLINE BEECHAM CORP [US], et al) [Y] 1-5 * see p.2, line 21, see claims ; column W ;
		[Y]WO9701540 (SMITHKLINE BEECHAM CORP [US], et al) [Y] 1-5 * see p. 3, line 10, see claims ; column W ;
		[Y]WO9911626 (SMITHKLINE BEECHAM CORP [US], et al) [Y] 1-5 * see p.3, line 15, see claims ; column W ;
		[Y] - ELLISON J A ET AL, "OSTEOPONTIN AND ITS INTEGRIN RECEPTOR ALPHAVBETA3 ARE UPREGULATED DURING FORMATION OF THE GLIAL SCAR AFTER FOCAL STROKE", STROKE, AMERICAN HEART ASSOCIATION, DALLAS TX, US, (199808), vol. 29, no. 8, ISSN 0039-2499, pages 1698 - 1706, XP001029459 [Y] 1-5 * see p.1705, par. bridging left/right col. ; column W
	International search	[T]WO9814192 (SMITHKLINE BEECHAM CORP [US], et al)
		[PT] - MILLER ET AL., "Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine gly-asp mimetic", JOURNAL MEDICINAL CHEMISTRY,, (20000113), vol. 43, no. 1, pages 22 - 26, XP002931378 DOI: http://dx.doi.org/10.1021/jm990446u

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p